Clark, NJ – July 10, 2014 – GEP, a leading provider of procurement and supply chain solutions to Fortune 500 and Global 2000 enterprises worldwide, is pleased to announce that it has been selected by global biopharmaceuticals leader Bristol-Myers Squibb (NYSE:BMY) to provide procurement services under a multiyear agreement.
GEP will help Bristol-Myers Squibb identify cost savings opportunities from its global spending.
“We’re delighted to have been selected by Bristol-Myers Squibb to support their ongoing procurement activities,” said Neha Shah, executive vice president & co-founder of GEP. “Together, we’ll be working to maximize the efficiency and effectiveness of the company’s procurement resources across multiple categories. This strategy will help Bristol-Myers Squibb seek cost savings and leverage internal talent in new ways, creating opportunities that drive the greatest long-term value for patients and shareholders.”
GEP is a diverse, creative team of people passionate about procurement. We invest ourselves entirely in our client's success, creating strong collaborative relationships that deliver extraordinary value year after year. We deliver practical, effective procurement services and technology that enable procurement leaders to maximize their impact on business operations, strategy and financial performance.
Named a Star Performer in Everest Group's Peak Matrix of Procurement Services Providers, Winner in the HfS Blueprint Report on Procurement Outsourcing Providers and to the Supply & Demand Chain Executive 100 for nearly a decade, GEP is also ranked a leader on Gartner's Magic Quadrant analysis of the world's top procurement software providers. Clark, NJ-based GEP has 10 offices and operations centers in Europe, Asia and the Americas.
To learn more about our comprehensive range of consulting and outsourcing services, please visit www.gep.com. For more about SMART by GEP, our unified sourcing and procurement software platform, please visit www.smartbygep.com.
Global VP, Marketing & Analyst Relations